Home > Resources > Whitepapers > Solid Dosage and Excipients

Solid Dosage and Excipients

April 24, 2019

For many reasons from ease of administration to dosing accuracy to manufacturing efficiency pharmaceutical manufacturers prefer to formulate their APIs as solid dosage drugs, and particularly tablets. There is significant room, however, for improvement of tableting processes. Advances in tableting technology, including continuous production equipment and the process analytical technology (PAT) and software required for effective continuous commercial-scale production, are helping to increase reproducibility, accuracy, and consistency

Spotlight

Novis Pharmaceuticals, LLC

NOVIS Pharmaceuticals is a nationwide licensed and authorized distributor for some of the world’s leading manufacturers of critical care products: plasma derivatives, albumin, immune globulins, coagulation factors and hyperimmunes. Our product line includes the most sensitive therapeutics in medicine used to treat trauma, autoimmune conditions, immune deficiencies, infectious diseases, bleeding disorders, and other life-threatening conditions. We service hospitals, home care organizations and infusion companies, physician offices, and pharmacy benefit management companies.

OTHER WHITEPAPERS

The Globalization Of The Pharmaceutical Industry

whitePaper | July 7, 2023

Rapid globalization has brought both opportunity and challenges for the pharmaceutical industry. Established healthcare markets are placing increased demands on industry to ensure products are beneficial, safe and available for patients and to improve how information is shared.